opioid abuse

Amid the ongoing opioid crisis, Purdue Pharma has proposed a new bankruptcy plan. The pharmaceutical giant is offering a settlement of at least $7.4 billion to address its role in the crisis. What Happened: On Tuesday, the OxyContin maker submitted a revised bankruptcy plan, offering a settlement...

Researchers are exploring the potential of cannabidiol (CBD), a component of marijuana, as an alternative to naloxone, a rapid-acting opioid antidote that is less effective against strong synthetic opioids such as fentanyl. CBD-based compounds have been found to reduce fentanyl binding and enhance...

Delta-9 THC, marijuana’s active ingredient, is the most common substance appearing on positive drug tests in those working in the military full time, reported Marijuana Moment. According to a letter from the Department of Defense (DOD) addressing Sen. Ed Markey (D-MA)’s request from...

Kratom grows in several Asian countries and has been traditionally used by local communities as a natural home remedy for pain, depression and addiction. Now, several psychedelics companies are developing substances based on this plant and several US states have already enacted legislation that...

Novamind Inc. (OTCQB: NVMDF), a mental health company specializing in psychedelic medicine, has announced the launch of a new clinic located in downtown Salt Lake City specializing in integrative behavioral health and services for adults with substance use disorders.  The company notes that in...

A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reuters reported. Washington Attorney General Bob Ferguson...

Oklahoma’s Supreme Court struck down a 2019 ruling against Johnson & Johnson (NYSE: JNJ) and overturned a $465 million fine, finding a judge incorrectly interpreted public nuisance laws. The 5-to-1 decision that overturned the $465 million verdict issued by Cleveland...

Opioid legislation recently passed in the House of Representatives includes a temporary lift on the ban on Medicaid funding for substance use disorder and the definition of eligible institutions for mental disease facilities, according to Height Capital Markets.  The Thesis The bill...

The U.S. Food and Drug Administration reached a conclusion this week concerning Endo International plc - Ordinary Shares (NASDAQ: ENDP)'s therapy Opana ER, which is intended to treat pain severe enough to require a daily, around-the-clock, long-term opioid treatment. An independent FDA panel...

Egalet Corp (NASDAQ: EGLT) was surely one of the most watched biotechs of the fourth quarter of 2016. After the company announced the Food and Drug Administration would miss its PDUFA decision date for Egalet’s opioid-based pain medication ARYMO ER, investors waited impatiently for news of a...

Biotech traders may want to keep an eye on Collegium Pharmaceuticals Inc (NASDAQ: COLL) on Thursday morning, as the stock may see increased activity due to an expert networking call between investors and an expert discussing the company's drug Xtampza ER. On April 27, the FDA approved Collegium's...